Literature DB >> 28838995

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells.

Falk Heidenreich1,2, Elke Rücker-Braun2,3, Juliane S Walz4, Anne Eugster3, Denise Kühn3, Sevina Dietz3, Annika Nelde4,5, Antje Tunger6,7, Rebekka Wehner6,7, Cornelia S Link2,3, Jan M Middeke2, Friedrich Stölzel2, Torsten Tonn8, Stefan Stevanovic5,9,10, Hans-Georg Rammensee5,9,10, Ezio Bonifacio3, Michael Bachmann3,7,10,11,12, Matthias Zeis13, Gerhard Ehninger2,3,7,10,11, Martin Bornhäuser2,3,7,10,11, Johannes Schetelig14,2, Marc Schmitz3,6,7,10,11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28838995      PMCID： PMC5664409          DOI： 10.3324/haematol.2017.167312

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Measuring T cell receptor and T cell gene expression diversity in antigen-responsive human CD4+ T cells.

Authors:  Anne Eugster; Annett Lindner; Anne-Kristin Heninger; Carmen Wilhelm; Sevina Dietz; Mara Catani; Anette-G Ziegler; Ezio Bonifacio
Journal:  J Immunol Methods       Date:  2013-11-13       Impact factor: 2.303

2.  Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology.

Authors:  Antje Tunger; Rebekka Wehner; Malte von Bonin; Denise Kühn; Falk Heidenreich; Sarah Matko; Magdalena Nauerth; Elke Rücker-Braun; Sevina Dietz; Cornelia S Link; Anne Eugster; Marcus Odendahl; Dirk H Busch; Torsten Tonn; Ezio Bonifacio; Lothar Germeroth; Johannes Schetelig; Michael P Bachmann; Martin Bornhäuser; Marc Schmitz
Journal:  Leuk Lymphoma       Date:  2016-11-16

3.  Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.

Authors:  Ashwini Balakrishnan; Tracy Goodpaster; Julie Randolph-Habecker; Benjamin G Hoffstrom; Florencia G Jalikis; Lisa K Koch; Carolina Berger; Paula L Kosasih; Anusha Rajan; Daniel Sommermeyer; Peggy L Porter; Stanley R Riddell
Journal:  Clin Cancer Res       Date:  2016-11-16       Impact factor: 12.531

4.  Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.

Authors:  Pedro Romero; Alfred Zippelius; Isabel Kurth; Mikaël J Pittet; Cédric Touvrey; Emanuela M Iancu; Patricia Corthesy; Estelle Devevre; Daniel E Speiser; Nathalie Rufer
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

5.  Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.

Authors:  Jian Yu; Liguang Chen; Bing Cui; George F Widhopf; Zhouxin Shen; Rongrong Wu; Ling Zhang; Suping Zhang; Steven P Briggs; Thomas J Kipps
Journal:  J Clin Invest       Date:  2016-02       Impact factor: 14.808

6.  Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.

Authors:  Tetsuya Fukuda; Liguang Chen; Tomoyuki Endo; Li Tang; Desheng Lu; Januario E Castro; George F Widhopf; Laura Z Rassenti; Mark J Cantwell; Charles E Prussak; Dennis A Carson; Thomas J Kipps
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

7.  The onco-embryonic antigen ROR1 is expressed by a variety of human cancers.

Authors:  Suping Zhang; Liguang Chen; Jessica Wang-Rodriguez; Ling Zhang; Bing Cui; Wendy Frankel; Rongrong Wu; Thomas J Kipps
Journal:  Am J Pathol       Date:  2012-10-04       Impact factor: 4.307

8.  Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.

Authors:  David L Porter; Wei-Ting Hwang; Noelle V Frey; Simon F Lacey; Pamela A Shaw; Alison W Loren; Adam Bagg; Katherine T Marcucci; Angela Shen; Vanessa Gonzalez; David Ambrose; Stephan A Grupp; Anne Chew; Zhaohui Zheng; Michael C Milone; Bruce L Levine; Jan J Melenhorst; Carl H June
Journal:  Sci Transl Med       Date:  2015-09-02       Impact factor: 17.956

9.  Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.

Authors:  Sivasubramanian Baskar; Ka Yin Kwong; Thomas Hofer; Jessica M Levy; Michael G Kennedy; Elinor Lee; Louis M Staudt; Wyndham H Wilson; Adrian Wiestner; Christoph Rader
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.

Authors:  Hema Dave; Miriam R Anver; Donna O Butcher; Patrick Brown; Javed Khan; Alan S Wayne; Sivasubramanian Baskar; Christoph Rader
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240
View more
  3 in total

1.  Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.

Authors:  Annika Nelde; Yacine Maringer; Tatjana Bilich; Helmut R Salih; Malte Roerden; Jonas S Heitmann; Ana Marcu; Jens Bauer; Marian C Neidert; Claudio Denzlinger; Gerald Illerhaus; Walter Erich Aulitzky; Hans-Georg Rammensee; Juliane S Walz
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

2.  Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens.

Authors:  Annika Nelde; Lea Flötotto; Klaus Wethmar; Lara Jürgens; Laura Szymik; Elvira Hubert; Jens Bauer; Christoph Schliemann; Torsten Kessler; Georg Lenz; Hans-Georg Rammensee; Juliane S Walz
Journal:  Cell Mol Life Sci       Date:  2022-03-03       Impact factor: 9.207

3.  Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome.

Authors:  Maddalena Marconato; Yacine Maringer; Juliane S Walz; Annika Nelde; Jonas S Heitmann
Journal:  Cancers (Basel)       Date:  2022-09-25       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.